151
Participants
Start Date
October 26, 2015
Primary Completion Date
June 15, 2017
Study Completion Date
June 15, 2017
Dapagliflozin 5 mg
Dapagliflozin, a blood glucose lowering drug. Oral dose
Dapagliflozin 10mg
Dapagliflozin, a blood glucose lowering drug. Oral dose
Research Site, Aizu Wakamatsu-shi
Research Site, Chūōku
Research Site, Fukuoka
Research Site, Fukuyama-shi
Research Site, Funabashi-shi
Research Site, Hamamatsu
Research Site, Hirosaki-shi
Research Site, Ise-shi
Research Site, Kagoshima
Research Site, Koriyama-shi
Research Site, Kumamoto
Research Site, Kunitachi-shi
Research Site, Minatoku
Research Site, Nagoya
Research Site, Oyama-shi
Research Site, Ōita
Research Site, Ōtsu
Research Site, Sapporo
Research Site, Sendai
Research Site, Shinjyuku-ku
Research Site, Suita-shi
Research Site, Tama-shi
Research Site, Tsukuba
Research Site, Yokohama
Lead Sponsor
AstraZeneca
INDUSTRY